The process of RNA editing is very common in the mammalian nervous system and provides a post-transcriptional mechanism for altering protein structure. Many proteins important for development and function in the nervous system are regulated through the action of RNA-specific adenosine deaminases (ADARs) (Mattick and Mehler, 2008) . Several of these gene products are ion channels, including the ligand-gated glutamate receptors. The editing of the AMPA and kainate subtypes of glutamate receptors causes a genomically encoded glutamine residue to be replaced by an arginine within the second transmembrane domain (Sommer et al., 1991) . This structural change results in reduced channel permeability to divalent cations (Burnashev et al., 1992) . Editing of the glutamate receptor subunits is vital for normal brain development and function, as mice engineered to produce only the unedited GluR2 subunit do not survive into adulthood (Brusa et al., 1995) .
Recently it was reported that the a3 subunit of the GABA A receptor (GABAR) also undergoes RNA editing by ADARs (Ohlson et al., 2007; Rula et al., 2008) . The result is a change in amino acid sequence within the third transmembrane domain (TM3) that replaces a highly conserved isoleucine residue with a methionine that is found only in the a3 subunit (Fig. 1) . The extent of this editing is developmentally regulated, with about 50% of the sites edited in the newborn rat brain increasing to nearly 100% edited in the adult. RNA editing has been shown to occur at four sites within the homologous RDL subunit of Drosophila (Hoopengardner et al., 2003; Es-Salah et al., 2008 ), but had not previously been shown in the vertebrate GABARs.
The GABARs are ligand-gated, chloride-permeable ion channels responsible for fast inhibitory neurotransmission. The GABARs exhibit substantial structural heterogeneity through the expression of at least 16 different subunits in the mammalian brain (Whiting et al., 1999) . There are six different subtypes within the a subunit family, each of which has a distinct, developmentally regulated, pattern of expression (Laurie et al., 1992a,b; Wisden et al., 1992) . The a3 subunit is one of the predominant a subunits in the embryonic brain, where it is widely and highly expressed. As development progresses, the a3 subunit is largely replaced by the a1 subunit, and its expression is restricted primarily to cortical neurons in the adult (Laurie et al., 1992a,b; Wisden et al., 1992) . Production of the a3 subunit can be influenced by pathological changes in the brain. An increase in a3 mRNA is observed during epileptogenesis (Brooks-Kayal et al., 1998 ) while a reduction is often observed following seizure onset (Poulter et al., 1999; Loup et al., 2006) . Animals lacking the a3 RNA editing provides a post-transcriptional mechanism to increase structural heterogeneity of gene products. Recently, the a3 subunit of the GABA A receptors has been shown to undergo RNA editing. As a result, a highly conserved isoleucine residue in the third transmembrane domain is replaced with a methionine. To determine the effect of this structural change on receptor function, we compared the GABA sensitivity, pharmacological properties and macroscopic kinetics of recombinant receptors containing either the edited or unedited forms of the a3 subunit along with b3 and g2L. Editing substantially altered the GABA sensitivity and deactivation rate of the receptors, with the unedited form showing a lower GABA EC 50 and slower decay. Comparable effects were observed with a mutation at the homologous location in the a1 subunit, suggesting a common role for this site in regulation of channel gating. Except for the response to GABA, the pharmacological properties of the receptor were unaffected by editing, with similar enhancement by a variety of modulators. Since RNA editing of the a3 subunit increases through development, our findings suggest that GABAergic neurotransmission may be more effective early in development, with greater GABA sensitivity and slower decay rates conferred by the unedited a3 subunit.
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